Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
643 participants
INTERVENTIONAL
2017-02-08
2029-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Persona Total Knee Arthroplasty Outcomes Study
NCT02255383
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
NCT05787821
Persona TM Tibia Clinical Outcomes Study
NCT03589300
Cemented vs Cementless Persona Keel RCT
NCT05630053
Persona Revision Knee System Outcomes
NCT04821154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All study subjects will undergo preoperative clinical evaluations prior to their partial knee arthroplasty. Investigators will collect clinical data for a required 2 years with the option to continue follow-up assessment up to 10 years. Follow-up clinical visits include 3 months, 1 year, 2, 5, and 10 years post-operatively.
The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available Persona Partial Knee System. The assessments will include: implant survivorship based on revision with removal of the study device; safety based on incidence and frequency of adverse events; and clinical performance measured by overall pain and function, quality of life data, radiographic parameters, and survivorship.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PPK subjects
Subjects that receive the Persona Partial Knee system
Persona Partial Knee system
Fixed bearing partial knee
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Persona Partial Knee system
Fixed bearing partial knee
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient qualifies for knee arthroplasty based upon physical exam and medical history, and meets the approved indications for use of the Persona Partial Knee system.
* Patient has participated in a study-related Informed Consent process
* Patient is willing and able to provide written Informed Consent by signing and dating the IRB/EC approved Informed Consent form
* Patient is willing and able to complete scheduled study procedures and follow-up evaluations
* Independent of study participation, patient is a candidate for the commercially available Persona Partial Knee, implanted in accordance with product labeling
Exclusion Criteria
* Infection, sepsis, and osteomyelitis
* Rheumatoid arthritis or other forms of inflammatory joint disease
* Insufficiency of the collateral, anterior or posterior cruciate ligaments which would preclude stability of the device
* Full thickness damage to the weight bearing area of the contralateral compartment
* Uncooperative patient or patient with neurologic disorders who is incapable of following directions
* Insufficient bone stock to provide adequate support and/or fixation to the prosthesis
* Metabolic disorders which may impair bone formation
* Osteomalacia
* Distant foci of infections which may spread to the implant site
* Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
* Vascular insufficiency, muscular atrophy, neuromuscular disease
* Incomplete or deficient soft tissue surrounding the knee
* Charcot's disease
* Fixed varus deformity (not passively correctable) of greater than 15 degrees
* Fixed flexion deformity (not passively correctable) of greater than 15 degrees
* Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hillary Overholser
Role: STUDY_DIRECTOR
Zimmer Biomet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sah Orthopaedic Associates
Fremont, California, United States
Panorama Orthopedics & Spine Center
Golden, Colorado, United States
Midwest Orthopaedics at Rush
Chicago, Illinois, United States
Henry County Orthopedics and Sports Medicine
New Castle, Indiana, United States
Sports Medicine North
Beverly, Massachusetts, United States
Troy Orthopaedic Associates
Troy, Michigan, United States
New Mexico Orthopaedics
Albuquerque, New Mexico, United States
Midlands Orthopaedics & Neurosurgery
Columbia, South Carolina, United States
Skagit Regional Clinics-Riverbend
Mount Vernon, Washington, United States
Orthopädisches Spital Speising
Vienna, , Austria
Cliniques Universitaires Saint-Luc
Woluwe-Saint-Lambert, , Belgium
Marseille University-Hospital Centres
Marseille, , France
Public Hospital of Versailles
Versailles, , France
Hessing Stiftung
Augsburg, , Germany
Sana Kliniken Sommerfeld
Berlin, , Germany
Waldkrankenhaus Eisenberg
Eisenberg, , Germany
Orthopedic Institute IRCCS
Milan, , Italy
Fondazione IRCCS Policlinico San Matteo
Pavia, , Italy
Hospital Alcorcón
Madrid, , Spain
Umea University Hospital
Umeå, , Sweden
Hopital d'Yverdon les Bains
Yverdon-les-Bains, , Switzerland
Avon Orthopaedic Centre, Southmead Hospital
Bristol, , United Kingdom
Royal Derby Hospital
Derby, , United Kingdom
Harrogate and District NHS Foundation Trust
Harrogate, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K.CR.I.G.16.16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.